USPTO serial 79034253
UNIBODY
Reviewed by CopyMark Law Group
Reg. 3312952Status 706Renewal
- Filing date
- Status date
- Registration date
- Oct 16, 2007
- Examiner
- GUTTADAURO, JULIE MARIE
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with UNIBODY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases | ACTIVE | — |
| 005 | Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infections diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases | ACTIVE | — |
| 042 | Medical and scientific research, namely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genmab A/S
- Other trademarks owned by Genmab A/S
- Other trademarks owned by Genmab A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named UNIBODY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 5, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 15, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 3, 2018 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 3, 2018 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 3, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 16, 2018 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 8, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 20, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 3, 2016 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 12, 2014 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | — |
| May 12, 2014 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 12, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 16, 2014 | 71AF | REGISTERED-SEC.71 FILED | — |
| Apr 16, 2014 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 11, 2011 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 15, 2010 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 15, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 8, 2008 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 8, 2008 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 28, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 28, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 22, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 16, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2007 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 31, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 26, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 25, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 24, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 31, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 31, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 14, 2007 | PAPER RECEIVED | — | |
| May 9, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2007 | FAXX | FAX RECEIVED | — |
| Mar 29, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 13, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 11, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2007 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Mar 1, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 1, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |